Stockscreener 앱 받기
20.81
0.24%
-0.05
시장 영업 전:
20.93
0.12
+0.58%
전일 마감가:
$20.86
열려 있는:
$21.03
하루 거래량:
5.97M
Relative Volume:
0.77
시가총액:
$10.75B
수익:
$11.32B
순이익/손실:
$-981.00M
주가수익비율:
-10.65
EPS:
-1.9532
순현금흐름:
$714.00M
1주 성능:
+8.16%
1개월 성능:
+20.29%
6개월 성능:
+6.55%
1년 성능:
-32.04%
1일 변동 폭
$20.77
$21.30
1주일 범위
$19.36
$21.30
52주 변동 폭
$15.73
$31.75
박스터 인터내셔널 Stock (BAX) Company Profile
명칭
Baxter International Inc
전화
(224) 948-2000
주소
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
20.81 | 10.75B | 11.32B | -981.00M | 714.00M | -1.9532 |
ISRG
Intuitive Surgical Inc
|
416.55 | 147.53B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
145.52 | 40.10B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
66.29 | 32.33B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.33 | 31.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
192.74 | 27.96B | 5.54B | 1.52B | 1.74B | 10.37 |
박스터 인터내셔널 Stock (BAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-31 | 다운그레이드 | Argus | Buy → Hold |
| 2025-08-04 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-08-01 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-02-26 | 재개 | Goldman | Buy |
| 2025-02-24 | 업그레이드 | Argus | Hold → Buy |
| 2025-02-20 | 재개 | Barclays | Overweight |
| 2024-07-15 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-12-15 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-12-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-06-24 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-18 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-18 | 재확인 | Raymond James | Outperform |
| 2022-02-18 | 재확인 | Stifel | Buy |
| 2022-02-18 | 재확인 | UBS | Neutral |
| 2022-02-18 | 재확인 | Wells Fargo | Overweight |
| 2022-02-11 | 개시 | Goldman | Neutral |
| 2022-01-07 | 재개 | Citigroup | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-09-03 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-12-15 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-09-04 | 다운그레이드 | Argus | Buy → Hold |
| 2020-06-24 | 개시 | Oppenheimer | Outperform |
| 2020-03-19 | 업그레이드 | Stifel | Hold → Buy |
| 2020-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-02 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-01-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-01-02 | 업그레이드 | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | 업그레이드 | Argus | Hold → Buy |
| 2018-10-16 | 개시 | Barclays | Underweight |
| 2018-05-17 | 재개 | Piper Jaffray | Overweight |
| 2018-02-06 | 재확인 | Citigroup | Neutral |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
모두보기
박스터 인터내셔널 주식(BAX)의 최신 뉴스
Baxter International stock outlook: Is Wall Street bullish or bearish? - MSN
Baxter International Inc. Stock (US0673431090): Analyst reiteration and modest NYSE move keep BAX in - AD HOC NEWS
Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with a Potential Upside - DirectorsTalk Interviews
Baxter (BAX) Stock After Recent Rebound Is The Discount To DCF Value Warranted - Yahoo Finance
Baxter International Inc. Stock (US0673431090): Analyst reiteration and NYSE move keep healthcare na - AD HOC NEWS
Baxter International Inc. Stock (US0673431090): Analyst reiteration and recent price move in focus - AD HOC NEWS
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter (BAX) Has an Installed-Base-and-Margin-Reset Story Bigger Than a Turnaround Trade - AlphaStreet
Baxter International Inc Stock (US0718131099): Valuation metrics keep S&P 500 healthcare name in foc - AD HOC NEWS
symbol__ Stock Quote Price and Forecast - CNN
Baxter International Inc. Stock (US0673431090): Earnings trends and valuation in focus - AD HOC NEWS
FMR LLC's Strategic Acquisition of Baxter International Inc. Sha - GuruFocus
Is Baxter International Inc. (BAX) A Good Stock To Buy Now? - Insider Monkey
Citi Downgrades Baxter International to Sell with Lower Price Target - HarianBasis.co
Baxter International Inc. stock underperforms Monday when compared to competitors - MSN
Why Baxter International Inc (BAX) May Struggle to Outperform: A Look at Future Challenges - GuruFocus
Baxter International (BAX) Faces Tough Road Ahead, Says Citi in Downgrade - Yahoo Finance
Baxter International Inc (BAX) Shares Surge 4.1% -- What GF Scor - GuruFocus
MediThinQ Exclusively Supplies 3D Surgical Solution to U.S. Baxter… “Challenging Global Standards for K-Medical Devices” - 벤처스퀘어
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
FMS and Home Dialysis: How 5008X Could Reset Demand - sharewise.com
World Gravity Infusion Administration SetsMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Baxter International Inc. (BAX): Investor Outlook Shows 11.15% Potential Upside Amid Healthcare Sector Dynamics - DirectorsTalk Interviews
Does Perceived Undervaluation at Baxter (BAX) Recast Its Margin Recovery and Portfolio Optimization Story? - simplywall.st
FMR LLC holds 10.3% of Baxter (NYSE: BAX) — 52.97M shares disclosed - Stock Titan
Is It Too Late to Buy Baxter International Inc (BAX) After 4.4% Rally? GF Value Says Undervalued - GuruFocus
Baxter International Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Baxter (BAX) interim CFO Anita Zielinski receives 13,426-share equity grant - Stock Titan
Baxter (BAX) surgery president forfeits shares to cover RSU tax bill - Stock Titan
Baxter (BAX) executive forfeits 321 shares to cover RSU tax withholding - Stock Titan
Baxter Introduces IV Verify Line Labeling System - Medical Product Outsourcing
Baxter Highlights Recent Sustainable Activities and Recognition - CSRwire
Baxter International Inc. stock (US0673431090): Shares ease around USD 18 after recent earnings and - AD HOC NEWS
Baxter International Inc. (BAX) Stock Analysis: Navigating the Healthcare Sector with a 14.71% Potential Upside - DirectorsTalk Interviews
Baxter International Inc. stock (US0673431090): shares steady on NYSE as investors watch technical s - AD HOC NEWS
Baxter and Its Foundation Contribute Nearly $44 Million in 2008 to Address Critical Needs Locally and Globally - CSRwire
Baxter International Inc. stock (US0673431090): shares trade near lower end of 52-week range on NYSE - AD HOC NEWS
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
Baxter International (BAX) Extends Losses, Approaches Critical Support ZoneGrowth Factor - The Legal Advocate
Baxter International (NY: BAX - FinancialContent
Why Baxter (BAX) Shares Are Sliding Today - Yahoo Finance
Baxter International Inc.: - marketscreener.com
Citi Downgrades Baxter International Inc(BAX.US) to Sell Rating, Cuts Target Price to $17 - Moomoo
Citigroup Downgrades Baxter International to Sell From Neutral, Adjusts PT to $17 From $19 - Moomoo
Baxter International Inc To Go Ex-Dividend On May 29th, 2026 With 0.01 USD Dividend Per Share - 富途牛牛
Baxter International Stock Surges 12%, With A 6-Day Winning Spree - Trefis
Baxter International Stock 6-Day Winning Spree: Stock Climbs 12% - Trefis
Baxter International Inc. (BAX) Stock Analysis: Navigating Healthcare’s Dynamic Terrain with 15% Upside Potential - DirectorsTalk Interviews
박스터 인터내셔널 (BAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.96%
0.18%
자본화:
|
볼륨(24시간):